sulfamethoxazole has been researched along with Polycystic Kidney Diseases in 2 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Polycystic Kidney Diseases: Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examines the causes for the therapeutic failure of trimethoprim-sulfamethoxazole in a patient with infected cysts caused by a sensitive strain of Escherichia coli." | 7.67 | Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. ( Schwab, SJ; Weaver, ME, 1986) |
| "This study examines the causes for the therapeutic failure of trimethoprim-sulfamethoxazole in a patient with infected cysts caused by a sensitive strain of Escherichia coli." | 3.67 | Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. ( Schwab, SJ; Weaver, ME, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elzinga, LW | 1 |
| Golper, TA | 1 |
| Rashad, AL | 1 |
| Carr, ME | 1 |
| Bennett, WM | 1 |
| Schwab, SJ | 1 |
| Weaver, ME | 1 |
2 other studies available for sulfamethoxazole and Polycystic Kidney Diseases
| Article | Year |
|---|---|
Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys.
Topics: Adult; Anti-Infective Agents, Urinary; Biological Availability; Enterococcus faecalis; Escherichia c | 1987 |
Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease.
Topics: Cysts; Drug Combinations; Drug Evaluation; Drug Synergism; Escherichia coli; Escherichia coli Infect | 1986 |